Drug Interactions between Barhemsys and Galafold
This report displays the potential drug interactions for the following 2 drugs:
- Barhemsys (amisulpride)
- Galafold (migalastat)
Interactions between your drugs
No interactions were found between Barhemsys and Galafold. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Barhemsys
A total of 379 drugs are known to interact with Barhemsys.
- Barhemsys is in the drug class miscellaneous antiemetics.
- Barhemsys is used to treat Nausea/Vomiting, Postoperative.
Galafold
A total of 1 drugs are known to interact with Galafold.
- Galafold is in the drug class miscellaneous metabolic agents.
- Galafold is used to treat Fabry Disease.
Drug and food interactions
migALAstat food
Applies to: Galafold (migalastat)
ADJUST DOSING INTERVAL: Food may reduce the oral bioavailability of migalastat. When migalastat was administered one hour before a high-fat (850 calories; 56% from fat) or light meal (507 calories; 30% from fat), or one hour after a light meal, mean migalastat peak plasma concentration (Cmax) decreased by 15% to 39% and systemic exposure (AUC) decreased by 37% to 42% compared to administration in the fasting state.
MANAGEMENT: Migalastat should be taken on an empty stomach. Patients should avoid eating for at least 2 hours before and 2 hours after taking migalastat to give a minimum 4 hours fast. Clear liquids can be consumed during this 4-hour period.
References
- Canadian Pharmacists Association (2006) e-CPS. http://www.pharmacists.ca/function/Subscriptions/ecps.cfm?link=eCPS_quikLink
- (2018) "Product Information. Galafold (migalastat)." Amicus Therapeutics U.S., Inc.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.